Abiopharma

🔍 LAMBERT CHARLES R (Executive)

Company: MEDICAL PROPERTIES TRUST INC (MPT)

Report Date: 2026-03-18

Detailed Transactions and Holdings:

• Acquired 50,000 shares of Common stock, par value $0.001 (Direct)
  Date: 2026-03-18 | Code: A | equity_swap_involved: false | shares_owned_after: 367,401.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 25,000 shares of Common stock, par value $0.001 (Direct)
  Date: 2026-03-18 | Code: A | equity_swap_involved: false | shares_owned_after: 392,401.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.
• F2: Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's reduction of overall debt and cash revenue growth, as defined and set by our compensation committee, over the period from January 1, 2026 through December 31, 2028, with the opportunity to earn up to one third of the award for 2026 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of these specific performance thresholds.